Study protocol of the TRICOLORE trial: a randomized phase III study of oxaliplatin-based chemotherapy versus combination chemotherapy with S-1, irinotecan, and bevacizumab as first-line therapy for metastatic colorectal cancer

BACKGROUND: Metastatic colorectal cancer carries a poor prognosis and cannot be cured by currently available therapy. Chemotherapy designed to prolong survival and improve the quality of life (QOL) of patients is the mainstay of treatment. Standard regimens of FOLFOX/bevacizumab and CapeOX/bevacizum...

Celý popis

Uloženo v:
Podrobná bibliografie
Vydáno v:BMC Cancer
Hlavní autoři: Komatsu, Yoshito, Ishioka, Chikashi, Shimada, Ken, Yamada, Yasuhide, Gamoh, Makio, Sato, Atsushi, Yamaguchi, Tatsuro, Yuki, Satoshi, Morita, Satoshi, Takahashi, Shin, Goto, Rei, Kurihara, Minoru
Médium: Artigo
Jazyk:Inglês
Vydáno: BioMed Central 2015
Témata:
Study Protocol
On-line přístup:https://ncbi.nlm.nih.gov/pmc/articles/PMC4565014/
https://ncbi.nlm.nih.gov/pubmed/26353772
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/s12885-015-1630-1
Tagy: Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!

Podobné jednotky